BACKGROUND: Bone loss is an important problem in renal transplant recipients immediately after surgery. No data are available about the bone loss beyond the first post-transplantation year. METHODS: In a longitudinal, uncontrolled observational study bone mineral density (BMD) was measured by dual X-ray absorptiometry in 115 renal graft recipients starting at different times after transplantation (0-20 years after transplantation) with a follow-up time of 12 months. RESULTS: A total of 56 patients showed a reduction of BMD during the observation period. Bone loss depended on the time after transplantation. Mean reduction of BMD at lumbar spine was 7 +/- 10%, 1 +/- 9% during the first and second postoperative year. Beyond the third year bone mineral density did not change or even increased slightly (0 +/- 4% during 3-5th year, 1 +/- 6% during 6-10th year and 2 +/- 4% during 11-20th year after transplantation). Decrease of BMD correlated with a higher mean daily prednisone dosage (P < 0.001), a higher cumulative prednisone dose (P < 0.01), a more frequent and more steroid-resistant rejection (P < 0.001) and a higher initial parathyroid hormone level (P < 0.001). Patients with 25-OH-cholecalciferol therapy (P < 0.05) or more physical activity (P < 0.05) had a smaller bone loss. CONCLUSIONS: Reduction of BMD after transplantation is highest within the first post-transplant year. The effects of acute graft rejection, prednisone dosage and initial parathyroid hormone level are predominant among the multiple factors associated with pronounced bone loss.
BACKGROUND:Bone loss is an important problem in renal transplant recipients immediately after surgery. No data are available about the bone loss beyond the first post-transplantation year. METHODS: In a longitudinal, uncontrolled observational study bone mineral density (BMD) was measured by dual X-ray absorptiometry in 115 renal graft recipients starting at different times after transplantation (0-20 years after transplantation) with a follow-up time of 12 months. RESULTS: A total of 56 patients showed a reduction of BMD during the observation period. Bone loss depended on the time after transplantation. Mean reduction of BMD at lumbar spine was 7 +/- 10%, 1 +/- 9% during the first and second postoperative year. Beyond the third year bone mineral density did not change or even increased slightly (0 +/- 4% during 3-5th year, 1 +/- 6% during 6-10th year and 2 +/- 4% during 11-20th year after transplantation). Decrease of BMD correlated with a higher mean daily prednisone dosage (P < 0.001), a higher cumulative prednisone dose (P < 0.01), a more frequent and more steroid-resistant rejection (P < 0.001) and a higher initial parathyroid hormone level (P < 0.001). Patients with 25-OH-cholecalciferol therapy (P < 0.05) or more physical activity (P < 0.05) had a smaller bone loss. CONCLUSIONS: Reduction of BMD after transplantation is highest within the first post-transplant year. The effects of acute graft rejection, prednisone dosage and initial parathyroid hormone level are predominant among the multiple factors associated with pronounced bone loss.
Authors: Elisa J Gordon; Thomas Prohaska; Laura A Siminoff; Peter J Minich; Ashwini R Sehgal Journal: Am J Kidney Dis Date: 2005-04 Impact factor: 8.860
Authors: Vincent M Brandenburg; Markus Ketteler; Nicole Heussen; Dirk Politt; Rolf D Frank; Ralf Westenfeld; Thomas H Ittel; Jürgen Floege Journal: Osteoporos Int Date: 2005-07-06 Impact factor: 4.507
Authors: Sapna P Iyer; Lucas E Nikkel; Kyle K Nishiyama; Elzbieta Dworakowski; Serge Cremers; Chiyuan Zhang; Donald J McMahon; Stephanie Boutroy; X Sherry Liu; Lloyd E Ratner; David J Cohen; X Edward Guo; Elizabeth Shane; Thomas L Nickolas Journal: J Am Soc Nephrol Date: 2014-02-07 Impact factor: 10.121
Authors: Amr A el-Husseini; Amgad E el-Agroudy; Ehab W Wafa; Tarek Mohsen; Mohamed A Sobh; Mohamed A Ghoneim Journal: Int Urol Nephrol Date: 2004 Impact factor: 2.370
Authors: Line M Vautour; L Joseph Melton; Bart L Clarke; Sara J Achenbach; Ann L Oberg; James T McCarthy Journal: Osteoporos Int Date: 2003-12-09 Impact factor: 4.507
Authors: Elisa J Gordon; Thomas R Prohaska; Mary P Gallant; Ashwini R Sehgal; David Strogatz; David Conti; Laura A Siminoff Journal: Clin Transplant Date: 2009-11-18 Impact factor: 2.863